Fotagliptin benzoate is a Dipeptidyl Peptidase IV (DPP-4) inhibitor (IC50=2.27 nM). Fotagliptin benzoate displays great security in rat and dog. Fotagliptin benzoate can be used for Type 2 diabetes mellitus research.
Fotagliptin benzoate (33 mg/kg or 110 mg/kg) is safe for rat and dog at different doses respectively[1].
















